Alagkiozidis, I., Facciabene, A., Carpenito, C., Benencia, F., Jonak, Z., Adams, S., . . . Coukos, G. (2009). Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. BioMed Central.
Chicago-tyylinen lähdeviittausAlagkiozidis, Ioannis, et al. Increased Immunogenicity of Surviving Tumor Cells Enables Cooperation between Liposomal Doxorubicin and IL-18. BioMed Central, 2009.
MLA-viiteAlagkiozidis, Ioannis, et al. Increased Immunogenicity of Surviving Tumor Cells Enables Cooperation between Liposomal Doxorubicin and IL-18. BioMed Central, 2009.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.